Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18134981 | 1.00 | L3MBTL1 (0.43) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL18134983 | 1.00 | L3MBTL1 (0.43) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL18134986 | 0.97 | HTT (0.44) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL18134990 | 0.97 | HTT (0.44) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL19763121 | 0.96 | HTT (0.40) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL19763116 | 0.96 | HTT (0.40) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL17604407 | 0.96 | HTT (0.40) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL14882819 | 0.96 | HTT (0.40) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL19763132 | 0.96 | HTT (0.40) | L3MBTL1HTTNPSR1CYP2A6TDP1 | |
| SCHEMBL5051402 | 0.96 | L3MBTL1 (0.43) | L3MBTL1HTTNPSR1CYP2A6TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170213986-A1 | CHARGE TRANSPORT MATERIAL | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-07-27 | — | — | US | disclosed |
| US-20160301011-A1 | ANILINE DERIVATIVES AND USES THEREOF | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-10-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160301011-A1 | ANILINE DERIVATIVES AND USES THEREOF | SLC18A1, SLC18A2, SLC43A1 | L3MBTL1 3759/4885HTT 2225/4885NPSR1 1347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.